142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Demonstrating a Framework for Aligning Public Health and Healthcare Efforts to Address Community Health Challenges

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 12:45 PM - 1:00 PM

Ron Bialek, MPP , Public Health Foundation, Washington, DC
Public health and healthcare can work in partnership, with defined roles and responsibilities, to positively impact the health of a community. During this presentation, a population health driver diagram framework developed and tested for successful collaboration and alignment of programs will be presented and discussed. The framework focuses on engaging the healthcare and public health communities to address specific health challenges.  Examples of population health driver diagrams to be discussed address issues such as optimal use of antibiotics, increased use of oral health services, and improving performance of vector control programs. Successes and success factors of this framework also will be discussed.

Learning Areas:

Program planning
Provision of health care to the public
Public health or related organizational policy, standards, or other guidelines
Public health or related research

Learning Objectives:
Describe how a driver diagram can be used to promote and sustain public health and healthcare collaboration. Identify three success factors of the population health driver diagram framework.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the director of several initiatives involving development and testing of population health driver diagrams. In addition, I have conducted workshops on the use of this framework for helping to align public health and healthcare efforts at the community level.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.